Figure 9E demonstrates that FASN transcript expression is higher in bladder tumor tissue than in normal tissue (p < 0.01). Additionally, GEPIA2 survival analysis demonstrates that the expression of FASN correlates to a poor overall survival rate in bladder cancer cases (Figure 9F). The gene discussed is FASN; the disease is urinary bladder cancer.